What a difference a year makes. When biotechnology execs and investors converged on the Palace Hotel in San Francisco last year for the two-day annual BIO Investor Forum, the biotech sector had just come through a tough third quarter in terms of fundraising, with public and private financings for the industry down 48 percent compared to 2010.